D Dressler
Overview
Explore the profile of D Dressler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
2308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klietz M, Schnur T, Drexel S, Lange F, Tulke A, Rippena L, et al.
Parkinsons Dis
. 2020 Mar;
2020:5184084.
PMID: 32184980
Parkinson's disease (PD) is a chronic progressive movement disorder with severe reduction in patients' health-related quality of life (HR-QoL). Motor and cognitive symptoms are especially linked with decreased PD patients'...
2.
Drexel S, Klietz M, Kollewe K, Paracka L, Kutschenko A, Kopp B, et al.
J Neural Transm (Vienna)
. 2019 Dec;
127(1):61-70.
PMID: 31802240
Dystonia is a chronic movement disorder that is associated with a reduction in health-related quality of life (HR-QoL) and restriction of activities of daily living. Botulinum neurotoxin (BT) improves disease-specific...
3.
Klietz M, Rippena L, Lange F, Tulke A, Paracka L, Dressler D, et al.
Int Psychogeriatr
. 2019 Mar;
31(12):1791-1800.
PMID: 30907331
Background: Advanced Parkinson's disease (PD) may place a high burden on patients and their caregivers. Understanding the determinants of caregiver burden is of critical importance. This understanding requires the availability...
4.
Fheodoroff K, Dressler D, Woldag H, Kossmehl P, Koch M, Maisonobe P, et al.
Nervenarzt
. 2018 Oct;
90(4):361-370.
PMID: 30324541
Background: The ULIS-II was an international cohort study (NCT01020500) evaluating current treatment of upper limb spasticity in post-stroke adult patients with botulinum toxin A (BoNT-A) in real-life practice. Objective: Post...
5.
Hentschel F, Dressler D, Abele M, Paus S
J Neural Transm (Vienna)
. 2016 Nov;
124(2):245-251.
PMID: 27816992
Causes of cardiovascular autonomic dysfunction in cervical dystonia (CD) are poorly understood. Studies examining effects of botulinum neurotoxin (BoNT) therapy on heart rate variability (HRV) yielded contradictory results. There is...
6.
Dressler D
J Neural Transm (Vienna)
. 2015 Nov;
123(3):277-9.
PMID: 26559824
The global botulinum toxin (BT) market is currently undergoing rapid changes: this may be the time to review the history and the future of BT drug development. Since the early...
7.
Dressler D, Berweck S, Chatzikalfas A, Ebke M, Frank B, Hesse S, et al.
J Neural Transm (Vienna)
. 2015 Jul;
122(11):1573-9.
PMID: 26179478
Continuous intrathecal Baclofen application (ITB) through an intracorporeal pump system is widely used in adults and children with spasticity of spinal and supraspinal origin. Currently, about 1200 new ITB pump...
8.
Dressler D, Kupsch A, Seitzinger A, Paus S
Eur J Neurol
. 2014 Jan;
21(3):459-62.
PMID: 24433495
Background And Purpose: Conventional scales measure the effect of botulinum toxin (BT) therapy only at specific points in time. The Dystonia Discomfort Scale (DDS), a novel, easy-to-use, self-assessment scale to...
9.
Walter U, Blitzer A, Benecke R, Grossmann A, Dressler D
Eur J Neurol
. 2013 Apr;
21(2):349-52.
PMID: 23581276
Background And Purpose: Abnormalities of the lenticular nucleus (LN) on transcranial sonography (TCS) are a characteristic finding in idiopathic segmental and generalized dystonia. Our intention was to study whether TCS...
10.
Dressler D
HNO
. 2012 Jun;
60(6):496-502.
PMID: 22669438
Botulinum toxin (BT) is used with remarkable success to treat various disorders caused by muscle hyperactivities or exocrine gland overactivity. Its use for treatment of non-muscular pain conditions is currently...